Security key
47103J105
Janux Therapeutics, Inc. - Common Stock (JANX)
CUSIP: 47103J105
Q3 2023 13F Holders as of 30 Sep 2023
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 60,817,522
- Total 13F shares
- 35,112,124
- Share change
- +4,603,293
- Total reported value
- $353,984,587
- Put/Call ratio
- 17%
- Price per share
- $10.08
- Number of holders
- 57
- Value change
- +$45,518,472
- Number of buys
- 32
- Number of sells
- 22
Report period
Q3 2023
Institutions
57
Top holders
10
JANX full security history
Newer quarter: Q4 2023
Previous quarter: Q2 2023
Janux Therapeutics, Inc. SEC filings
Janux Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 47103J105
Recent filing periods:
Top shareholders of JANX - Janux Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
14%
|
8,670,644
|
$102,920,544 | — | 30 Jun 2023 | |
| FMR LLC |
13F
|
Company |
8.3%
|
5,062,796
|
$60,095,389 | — | 30 Jun 2023 | |
| BVF INC/IL |
13F
|
Company |
6.8%
|
4,106,945
|
$48,749,437 | — | 30 Jun 2023 | |
| ORBIMED ADVISORS LLC |
13F
3/4/5
|
Company · Director |
4.7%
|
2,836,386
|
$33,667,902 | — | 30 Jun 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
3.5%
|
2,115,574
|
$25,111,864 | — | 30 Jun 2023 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
3.5%
|
2,109,338
|
$25,031,210 | — | 30 Jun 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2%
|
1,194,588
|
$14,179,758 | — | 30 Jun 2023 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.5%
|
900,000
|
$10,683,000 | — | 30 Jun 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.3%
|
761,990
|
$9,044,820 | — | 30 Jun 2023 | |
| EcoR1 Capital, LLC |
13F
|
Company |
0.74%
|
452,590
|
$5,372,243 | — | 30 Jun 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.62%
|
377,225
|
$4,477,660 | — | 30 Jun 2023 | |
| Samsara BioCapital, LLC |
13F
|
Company |
0.59%
|
360,414
|
$4,278,114 | — | 30 Jun 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.55%
|
332,590
|
$3,947,843 | — | 30 Jun 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.31%
|
187,290
|
$2,223,132 | — | 30 Jun 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.25%
|
153,436
|
$1,821,286 | — | 30 Jun 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.23%
|
138,246
|
$1,640,980 | — | 30 Jun 2023 | |
| Woodline Partners LP |
13F
|
Company |
0.23%
|
137,300
|
$1,629,751 | — | 30 Jun 2023 | |
| Cerity Partners LLC |
13F
|
Company |
0.1%
|
60,933
|
$723,275 | — | 30 Jun 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.1%
|
58,745
|
$697,303 | — | 30 Jun 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.09%
|
53,049
|
$629,692 | — | 30 Jun 2023 | |
| Deutsche Girozentrale DekaBank |
13F
|
Individual |
0.08%
|
49,500
|
$571,000 | — | 30 Jun 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.08%
|
46,121
|
$547,456 | — | 30 Jun 2023 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.05%
|
27,780
|
$329,749 | — | 30 Jun 2023 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.04%
|
26,778
|
$317,854 | — | 30 Jun 2023 | |
| Swiss National Bank |
13F
|
Company |
0.04%
|
22,800
|
$270,636 | — | 30 Jun 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.04%
|
22,719
|
$269,675 | — | 30 Jun 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.03%
|
21,147
|
$251,016 | — | 30 Jun 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.03%
|
18,481
|
$219,368 | — | 30 Jun 2023 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.03%
|
15,899
|
$188,721 | — | 30 Jun 2023 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.02%
|
15,030
|
$178,406 | — | 30 Jun 2023 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.02%
|
14,952
|
$177,480 | — | 30 Jun 2023 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.02%
|
14,935
|
$177,278 | — | 30 Jun 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.02%
|
14,800
|
$176,000 | — | 30 Jun 2023 | |
| XTX Topco Ltd |
13F
|
Company |
0.02%
|
13,215
|
$156,862 | — | 30 Jun 2023 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.02%
|
13,202
|
$156,708 | — | 30 Jun 2023 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.02%
|
12,641
|
$150,049 | — | 30 Jun 2023 | |
| Jump Financial, LLC |
13F
|
Company |
0.02%
|
10,821
|
$128,446 | — | 30 Jun 2023 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0.02%
|
10,614
|
$125,988 | — | 30 Jun 2023 | |
| Legal & General Group Plc |
13F
|
Company |
0.02%
|
10,194
|
$121,004 | — | 30 Jun 2023 | |
| EXCHANGE TRADED CONCEPTS, LLC |
13F
|
Company |
0.02%
|
10,010
|
$118,819 | — | 30 Jun 2023 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.01%
|
8,324
|
$98,806 | — | 30 Jun 2023 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
6,973
|
$82,770 | — | 30 Jun 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
6,633
|
$78,734 | — | 30 Jun 2023 | |
| CITIGROUP INC |
13F
|
Company |
0.01%
|
5,787
|
$68,691 | — | 30 Jun 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
5,479
|
$65,035 | — | 30 Jun 2023 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.01%
|
5,030
|
$59,706 | — | 30 Jun 2023 | |
| AMALGAMATED BANK |
13F
|
Company |
0%
|
1,766
|
$21,000 | — | 30 Jun 2023 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
1,759
|
$21,000 | — | 30 Jun 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,597
|
$18,956 | — | 30 Jun 2023 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0%
|
1,532
|
$18,184 | — | 30 Jun 2023 |
Institutional Holders of Janux Therapeutics, Inc. - Common Stock (JANX) as of Q3 2023
As of 30 Sep 2023,
Janux Therapeutics, Inc. - Common Stock (JANX) was held by
57 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,112,124 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., FMR LLC, BVF INC/IL, CITADEL ADVISORS LLC, ORBIMED ADVISORS LLC, JANUS HENDERSON GROUP PLC, BlackRock Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
57
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
54
Q3 2023 holders
57
Holder diff
3
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 Value $ | Q3 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.